Posted: 6/20/2017 11:20:10 AM EDT
|
I mentioned this one in my last stock thread and have been crushing it recently after buying on a big dip. Y'all may want to take a look.
And yes I still have a position in it so I am obviously biased. |
|
Quoted:
Could you guys describe the play here. They are losing their shirt, lost $10 a share and the hepatic drug is successful but not selling. The stock reverse split failed so pump and dump or did I miss something? This is a real question not trying to be a jerk. |
| IMO the big upside potential is their chemostat getting FDA approval this year or a buyout. Their product works well and the US market is way more profitable for these companies than the European market. They have two clinical trials ongoing (I believe one concluded last week and the results from that should have an effect on price) that will be telling. |
| On the reverse split, it didn't fail, it got voted down. One way to interpret that (which I believe is why we've seen big price swings) is that the company feels it does not need a reverse split to get the price to $1. If that it true, then they may have good news coming (hopefully the results of the new trial). |